General Information of the Compound
Compound ID
CP0430004
Compound Name
4-[4-(3-naphthalen-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]butanoic acid
    Show/Hide
Structure
Formula
C21H23N3O3
Molecular Weight
365.433
Canonical SMILES
OC(=O)CCCN1CCC(CC1)c1nc(no1)-c1ccc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C21H23N3O3/c25-19(26)6-3-11-24-12-9-16(10-13-24)21-22-20(23-27-21)18-8-7-15-4-1-2-5-17(15)14-18/h1-2,4-5,7-8,14,16H,3,6,9-13H2,(H,25,26)
    Show/Hide
InChIKey
LWHDDWRMDZBFEN-UHFFFAOYSA-N
Physicochemical Property
logP
3.934
Rotatable Bonds
6
Heavy Atom Count
27
Polar Areas
79.46
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 151011965
ChEMBL ID
CHEMBL4573467
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 25700 nM
   TI
   LI
   LO
   TS